MEOBF: Mesoblast Limited Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,066.79
Enterprise Value ($M) 1,066.79
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.90
Operating Income -56.22
Net Income -87.96

Cash Flow Statement (mra) ($M)
Cash From Operations -48.46
Cash from Investing -0.10
Cash from Financing 40.25

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
MDCLF – MedinCell S.A. MDIN – MedGen, Inc.
MDRM – Modern Mobility Aids, Inc. MITPF – Mithra Pharmaceuticals SA
MIXX – Mix1 Life, Inc.


Financial data and stock pages provided by
Fintel.io